Conduit Pharmaceuticals Inc (NASDAQ: CDT) is -82.65% lower on its value in year-to-date trading and has touched a low of $1.13 and a high of $392.00 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The CDT stock was last observed hovering at around $1.18 in the last trading session, with the day’s gains setting it 0.01%.
Currently trading at $1.19, the stock is -48.60% and -78.73% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.24 million and changing 0.85% at the moment leaves the stock -98.01% off its SMA200. CDT registered -99.60% loss for a year compared to 6-month loss of -92.48%.
The stock witnessed a -82.37% gain in the last 1 month and extending the period to 3 months gives it a -86.07%, and is -33.15% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 17.93% over the week and 25.07% over the month.
Conduit Pharmaceuticals Inc (CDT) has around 7 employees, a market worth around $4.34M and $0.00M in sales. Distance from 52-week low is 5.31% and -99.70% from its 52-week high.
The shares outstanding are 0.96M, and float is at 0.72M with Short Float at 31.06%.
Conduit Pharmaceuticals Inc (CDT) Insider Activity
The most recent transaction is an insider sale by Nirland Ltd, the company’s 10% Owner. SEC filings show that Nirland Ltd sold 1,500,000 shares of the company’s common stock on Oct 03 ’24 at a price of $0.10 per share for a total of $0.16 million. Following the sale, the insider now owns 8.4 million shares.
Conduit Pharmaceuticals Inc disclosed in a document filed with the SEC on Oct 04 ’24 that Nirland Ltd (10% Owner) sold a total of 1,368,991 shares of the company’s common stock. The trade occurred on Oct 04 ’24 and was made at $0.10 per share for $0.14 million. Following the transaction, the insider now directly holds 7.03 million shares of the CDT stock.
Still, SEC filings show that on Oct 07 ’24, Nirland Ltd (10% Owner) disposed off 939,009 shares at an average price of $0.10 for $96530.0. The insider now directly holds 6,092,000 shares of Conduit Pharmaceuticals Inc (CDT).
